Is Scisparc Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Scisparc Ltd (SPRC) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Scisparc Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Scisparc Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Scisparc Ltd?

Muslim investors may consider investing in Scisparc Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Scisparc Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Scisparc Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Scisparc Ltd updated?

The Shariah compliance status of Scisparc Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Scisparc Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Scisparc Ltd?

You can check the latest Shariah compliance status of Scisparc Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SPRC Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 18, 2026

Report Source: 2025 2nd Quarter Report

Scisparc Ltd. Stock Analysis SPRC

United States Health Care Nano Cap Report: Q2, 2025

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Key Statistics of Scisparc Ltd (SPRC)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.82$5.00

Today's Open

$5.00

Volume

4748.00

P/E Ratio (TTM)

52 Week Range

$2.98$80.10

Market Cap

3.96M

Avg. Volume

922.74K

Dividend Yield

Financial Metrics & Statements of Scisparc Ltd (SPRC)

FAQ's for Scisparc Ltd (SPRC)

According to Musaffa’s Shariah screening methodology, Scisparc Ltd (SPRC) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.